Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection

Yongkun Sun; Lin Yang; Chengfeng Wang; Dongbing Zhao; Jianqiang Cai; Wenbin Li; Wen Zhang; Jing Huang; Aiping Zhou

doi:10.18632/oncotarget.20660

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection

Yongkun Sun, Lin Yang _, Chengfeng Wang, Dongbing Zhao, Jianqiang Cai, Wenbin Li, Wen Zhang, Jing Huang and Aiping Zhou

PDF | HTML | How to cite

Oncotarget. 2017; 8:75186-75194. https://doi.org/10.18632/oncotarget.20660

Metrics: PDF 1268 views | HTML 1716 views | ?

Abstract

Yongkun Sun1, Lin Yang1, Chengfeng Wang1, Dongbing Zhao1, Jianqiang Cai1, Wenbin Li1, Wen Zhang1, Jing Huang1 and Aiping Zhou1

1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Correspondence to:

Lin Yang, email: [email protected]

Keywords: prognostic factors, locally advanced gastric cancer, neoadjuvant chemotherapy, gastrectomy

Received: February 07, 2017 Accepted: July 25, 2017 Published: September 06, 2017

ABSTRACT

In this retrospective study, we analyzed prognostic factors associated with survival outcomes in 73 locally advanced gastric cancer patients treated with neoadjuvant chemotherapy (NAC) followed by surgical resection. Median disease-free survival (DFS) for 64 patients that received R0 resection was 685 days, whereas median overall survival (OS) for 73 patients was 930 days. Multivariate analysis demonstrated that post-treatment nodal stages (P = 0.002), nervous invasion (P = 0.0492) and serum CA199 levels (P = 0.0398) were independent prognostic factors for DFS. Nodal stages (P = 0.0007), presence of nervous invasion (P = 0.0259) and non-radical resection (P = 0.0165) were independent prognostic factors for OS. These results indicate that post-treatment nodal stages, neural invasion and serum CA199 levels are all associated with poor DFS. Moreover, post-treatment nodal stage, resection type and neural invasion status are independent prognostic factors for OS.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20660

Publication Alerts

Research Papers:

Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection

Abstract